Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

NCT05274880 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: CKD-393

Sponsor

Chong Kun Dang Pharmaceutical